Tau aggregates as immunotherapeutic targets

Biochemistry, Genetics and Molecular Biology

• Clearance 33%
• Electric Potential 16%
• Mouse Model 16%
• Neurofibrillary Tangle 66%
• Species 16%
• Tau 100%
• Tau Protein 16%

Neuroscience

• Alzheimer's Disease 16%
• Brain 16%
• Immunotherapy 16%
• In Vitro 16%
• In Vivo 16%
• Neurodegenerative Disorder 16%
• Oligomer 33%
• Tau Protein 16%
• Tauopathy 50%
• Treatment of Alzheimer's Disease 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Degenerative Disease 16%
• Immunotherapy 16%
• Neurofibrillary Tangle 66%
• Tau Protein 16%
• Tauopathy 50%